Illumina Inc (ILMN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: LABORATORY ANALYTICAL INSTRUMENTS

5200 ILLUMINA WAY SAN DIEGO, CA 92122

Develops and markets next-generation tools for the large-scale analysis of genetic variation and function. The company's tools help researchers gain information that could be used to enhance drug discovery, allow diseases to be detected earlier and permit better choices of drugs for patients.

Data based on most recent fiscal year report
Market Cap48.265 Billion Shares Outstanding147 Million Avg Volume1.333 Million
1-Yr BETA vs S&P TR1.188 Current Ratio2.49 Quick Ratio2.27
View SEC Filings from ILMN instead.

View recent insider trading info

Funds Holding ILMN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ILMN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

5.2 Thousand total shares from 8 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HAMPTON MALCOLM GARRET SVP CLINICAL GENOMICS GROUP

  • Officer
6,598 2020-01-09 2

ARNOLD FRANCES

  • Director
718 2020-01-08 2

HOYT AIMEE L SVP, CHIEF PEOPLE OFFICER

  • Officer
2,170 2020-01-08 3

SAMAD SAM SVP AND CFO

  • Officer
3,249 2020-01-06 3

TOUSI SUSAN H SVP PRODUCT DEVELOPMENT

  • Officer
38,465 2020-01-06 4

WALT DAVID R

1,222,310 2020-01-02 0

FLATLEY JAY T

  • Director
262,970 2020-01-02 16

STAPLEY MARC

  • Director
12,598 2020-01-02 0

VAN OENE MARK SVP CHIEF COMMERCIAL OFFICER

  • Officer
11,178 2020-01-02 6

POSARD MATTHEW L.

  • Director
29,263 2019-12-31 0

DESOUZA FRANCIS A

  • Director
4,080 2019-12-31 10

RASTETTER WILLIAM H

  • Director
0 2019-12-24 0

WHITFIELD ROY A

  • Director
218,250 2019-12-18 0

THOMPSON JOHN WENDELL

  • Director
28,345 2019-12-12 1

BRADBURY DANIEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
  • 10% Owner
0 2019-12-10 0

OSTADAN OMEAD SVP MKTG, PROD & STRAT PLAN

  • Officer
7,844 2019-12-10 7

GUTHART GARY S PRESIDENT & CEO

  • Officer
  • Director
371,728 2019-12-05 2

DADSWELL CHARLES SVP & GENERAL COUNSEL

  • Officer
3,576 2019-12-02 13

GOLDSTEIN JACK

  • Director
183,282 2019-11-29 0

MCGINNIS KAREN K VP, CHIEF ACCOUNTING OFFICER

  • Officer
2,153 2019-11-14 2

FEBBO PHILLIP G. SVP CHIEF MEDICAL OFFICER

  • Officer
1,506 2019-11-14 3

RONAGHI MOSTAFA SVP & CTO

  • Officer
75,407 2019-11-05 8

RAGUSA ROBERT P SVP, GLOBAL QUALITY & OPS

  • Officer
9,141 2019-11-05 4

HUBER JEFF

  • Director
82,195 2019-11-01 0

GOSWAMI JOYDEEP SVP CORP BUSINESS DEVELOPMENT

  • Officer
1,327 2019-10-07 2

EASTHAM KARIN

  • Director
15,000 2019-09-25 0

STUELPNAGEL JOHN R

  • Director
585,991 2019-09-16 0

HENRY CHRISTIAN O

  • Director
0 2019-08-15 0

BOWMAN A BLAINE

  • Director
0 2019-06-19 0

DORSA CAROLINE

  • Director
20,207 2019-06-19 2

EPSTEIN ROBERT S

  • Director
0 2019-06-12 6

SCHILLER PHILIP W

  • Director
9,085 2019-05-29 3

SIEGEL SUSAN E

  • Director
4,137 2019-05-29 3

MCCOMB JOEL

  • Director
0 2018-12-14 0

FLATLEY JAY T

  • Director
400,204 2018-09-12 16

KLAUSNER RICHARD

  • Director
No longer subject to file 2018-03-05 0

GRINT PAUL C CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
599 2017-12-08 0

BOUCHARD MICHEL CHIEF ACCOUNTING OFFICER

  • Officer
9,538 2017-11-06 0

ORPIN TRISTAN EVP CLINICAL GENOMICS

  • Officer
118,259 2016-11-07 0

BIANCHI PAUL L SR. VP, HUMAN RESOURCES

  • Officer
65,660 2016-04-18 0

NACLERIO NICHOLAS SR VP, CORPORATE DEVELOPMENT

  • Officer
30,020 2016-03-21 0

MOELLER GERALD

  • Director
17,647 2015-03-31 0

HEATH GREGORY SR VP & GENERAL MANAGER

  • Officer
26,740 2013-12-17 0

LEWIS MARK L SR VP & GENERAL MANAGER

  • Officer
44,837 2013-11-01 0

CABOU CHRISTIAN SR VP & GENERAL COUNSEL

  • Officer
46,553 2013-04-23 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HAMPTON MALCOLM GARRET - Officer SVP CLINICAL GENOMICS GROUP

2020-01-09 F 326 $334.60 d 6,598 6,598.00 direct

HOYT AIMEE L - Officer SVP, CHIEF PEOPLE OFFICER

2020-01-08 F 156 $332.16 d 2,170 2,170.00 direct

SAMAD SAM - Officer SVP AND CFO

2020-01-06 F 212 $325.53 d 3,249 3,249.00 direct

TOUSI SUSAN H - Officer SVP PRODUCT DEVELOPMENT

2020-01-06 S 200 $325.00 d 38,465 38,465.00 direct

VAN OENE MARK - Officer SVP CHIEF COMMERCIAL OFFICER

2020-01-02 S 400 $331.33 d 11,178 11,178.00 direct

VAN OENE MARK - Officer SVP CHIEF COMMERCIAL OFFICER

2020-01-02 S 225 $330.38 d 11,578 11,178.00 direct

FLATLEY JAY T - Director

2020-01-02 A 446 a 258,970 262,970.00 direct

FLATLEY JAY T - Director

2019-12-11 F 3,015 $320.57 d 258,524 262,524.00 direct

OSTADAN OMEAD - Officer SVP MKTG, PROD & STRAT PLAN

2019-12-10 S 1,200 $326.01 d 7,844 7,844.00 direct

TOUSI SUSAN H - Officer SVP PRODUCT DEVELOPMENT

2019-12-06 S 1,000 $325.00 d 38,665 38,665.00 direct

VAN OENE MARK - Officer SVP CHIEF COMMERCIAL OFFICER

2019-12-02 S 625 $320.15 d 11,803 11,803.00 direct

DADSWELL CHARLES - Officer SVP & GENERAL COUNSEL

2019-12-02 S 655 $320.33 d 3,576 3,576.00 direct

SAMAD SAM - Officer SVP AND CFO

2019-11-29 S 892 $320.00 d 3,461 3,461.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments